361 Capital’s Thermo Fisher Scientific TMO Stock Holding History

361 Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,468	Closed	-$1.45M	–	387
2019 Q4	$1.45M	Buy	+4,468	New	+$1.35M	0.4%	71
2017 Q4	–	Sell	-14,121	Closed	-$2.67M	–	304
2017 Q3	$2.67M	Buy	14,121 +1,093	+8%	+$198K	0.51%	56
2017 Q2	$2.27M	Buy	+13,028	New	+$2.19M	0.38%	77

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

361 Capital's TMO Position: Q1 2020 in Review

361 Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2020, closing a stake of 4,468 shares — an estimated $1.45M sold.

361 Capital first reported a position in TMO in Q2 2017 and held it in 3 quarters. The position peaked at $2.67M in Q3 2017. 1,675 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

361 Capital reported no remaining Thermo Fisher Scientific position as of Q1 2020 after selling out during the quarter.
361 Capital sold 4,468 Thermo Fisher Scientific shares in Q1 2020, an estimated $1.45M.
361 Capital first reported a position in Thermo Fisher Scientific in Q2 2017 and held it in 3 quarters.
361 Capital's Thermo Fisher Scientific position peaked at $2.67M in Q3 2017.
1,675 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on 361 Capital's 13F filing for Q1 2020, filed 13 May 2020.